User Name:
Password:
Remember Login:
 
Forgot your password?
 
Or to join, click here.

 












BioHouston thanks our Associate Partners for their support!

Connected Solutions    Ernst & Young    FulBright & Jaworski L.L.P    Mayer Brown           

 
 
 
JOIN BIOHOUSTON

BioHouston is supported annually through corporate memberships.  Membership benefits are myriad—to view membership benefits and join, click here.
 
 
BIOHOUSTON RESOURCE CENTER

The BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to get to work producing proof-of-concept data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. For more information, click here.

Your support is needed—for more information, click here.
 
 
HIGHLIGHTS

 
OrthoAccel Technologies, Inc. was the winner of the 2007 Michael E. DeBakey Award and $25,000 cash prize. OrthoAccel Technologies, Inc. designs, develops, and markets a revolutionary device that cuts treatment time for braces in half and works in combination with all existing orthodontia bracket technologies. A panel of venture capitalists awarded OrthoAccel Technologies the DeBakey Life Science Award based on its exceptional potential in commercializing its technology. In addition to the $25,000 cash prize, OrthoAccel received a pro bono provisional patent filing from Baker & McKenzie LLP and premier visibility for the year in all BioHouston programs. To provide further support to the emerging companies that win this award, BioHouston offers winners low cost, short-term office space to help further close the funding gaps typically faced by these companies. OrthoAccel became our newest resident company at the beginning of 2008.
 
 
CURRENT BIOTECH NEWS

Fifteen Students Launch Into Space Research Internship

Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility and Testicular Function

Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe

Monebo and Freescale Partner to Deliver Innovative Heart Monitoring Platform

LDR Announces Release of its ROI-A™ Anterior Lumbar Partial Vertebral Body Replacement Device

PLx Pharma Demonstrates Bioequivalence with Aspirin and PL 2100 ~ Aspirin-PC

Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for Stem Cell Research Annual Meeting

Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin® for Multiple Sclerosis

Texas' Emerging Technology Fund Electrifies the Texas Economy

Kinetic Concept's V.A.C.(R) Therapy Recommendations for Six Wound Types Published

Introgen Creates Technical Services Company and Announces Strategic Alliance with Texas A&M University System to Expand GMP Manufacturing Programs

Repros Therapeutics Inc. Announces That Initial Findings for Proellex(R) Show No Gross Cancer Tumors in First Completed Animal Carcinogenicity Study

Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region

Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA


 
 
Why Choose to Attend this Breakfast? The Relationship of Psychology and Neuroscience in the Decisions We Make
 
 
Save the date! Sponsorship opportunities available...please contact Keisha Curtis at 713.979.9212.
 


Purchase the 2007/2008 Life Science Directory
 
BioHouston